Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease
Author(s) -
Erica Weitzner,
Donna McKenna,
John Nowakowski,
Carol Scavarda,
Rhea L. Dornbush,
Susan Bittker,
Denise R. Cooper,
Robert B. Nadelman,
Paul Visintainer,
Ira Schwartz,
Gary P. Wormser
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ735
Subject(s) - lyme disease , medicine , erythema migrans , borrelia burgdorferi , erythema chronicum migrans , dermatology , spirochaetaceae , erythema , surgery , immunology , lyme borreliosis , antibody
Lyme disease patients with erythema migrans are said to have post-treatment Lyme disease symptoms (PTLDS) if there is persistence of subjective symptoms for at least 6 months following antibiotic treatment and resolution of the skin lesion. The purpose of this study was to characterize PTLDS in patients with culture-confirmed early Lyme disease followed for >10 years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom